Physician profile
David Liu
NPI 1740501519
$10,474.59
in general payments reported to CMS, 2019-2025
7 companies · $1,516 in 2025
The $1,516 reported for 2025 was more than what a typical Medical Oncology provider received nationally (typical 2025 total: $1,158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $319 · 2024: $8,640 · 2025: $1,516.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $9,151 · Food and Beverage: $1,323.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $9,151.29 |
| Food and Beverage | $1,323.30 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| F. Hoffmann-La Roche Ag | $8,290.16 | 2024 | |
| Genentech, INC. | $1,448.14 | 2023-2025 | |
| Stryker Corporation | $291.12 | 2023-2024 | Restoration, Variax |
| Atricure, INC. | $190.88 | 2023-2024 | |
| Icotec Medical INC. | $188.70 | 2025 | Vader Pedicle System 6.0, Screw, Carbon/Peek, Polyax., Fen., O 5.5 X 45 Mm, Kong-Tl Vbr E, Expandable Body, L, 19 Mm X 27 - 37 Mm, Vader Pedicle System, Rod, Carbon/Peek, Curved, 6.0 R450 X 200 Mm |
| Genentech USA, INC. | $36.30 | 2023 | Tecentriq |
| Depuy Synthes Sales INC. | $29.29 | 2023 | Na, Tfn-Advance |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw David Liu listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.